BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bochicchio S, Lamberti G, Barba AA. Polymer-Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies. Pharmaceutics 2021;13:198. [PMID: 33540659 DOI: 10.3390/pharmaceutics13020198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Pinto IS, Cordeiro RA, Faneca H. Polymer- and lipid-based gene delivery technology for CAR T cell therapy. Journal of Controlled Release 2023;353:196-215. [DOI: 10.1016/j.jconrel.2022.11.038] [Reference Citation Analysis]
2 Chrysostomou V, Foryś A, Trzebicka B, Demetzos C, Pispas S. Amphiphilic Copolymer-Lipid Chimeric Nanosystems as DNA Vectors. Polymers 2022;14:4901. [DOI: 10.3390/polym14224901] [Reference Citation Analysis]
3 Jangid AK, Solanki R, Jadav M, Bora S, Patel S, Pooja D, Kulhari H. Phenyl Boronic Acid -PEG-Stearic acid biomaterial-based and Sialic acid Targeted Nanomicelles for Colon Cancer Treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2022. [DOI: 10.1016/j.colsurfa.2022.130445] [Reference Citation Analysis]
4 Elhassan E, Devnarain N, Mohammed M, Govender T, Omolo CA. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. Journal of Controlled Release 2022;351:598-622. [DOI: 10.1016/j.jconrel.2022.09.052] [Reference Citation Analysis]
5 Choi W, Cho H, Kim G, Youn I, Key J, Han S. Targeted thrombolysis by magnetoacoustic particles in photothrombotic stroke model. Biomater Res 2022;26:58. [PMID: 36273198 DOI: 10.1186/s40824-022-00298-y] [Reference Citation Analysis]
6 Ke WR, Yoon Kyung Chang R, Chan HK. Engineering the right formulation for enhanced drug delivery. Adv Drug Deliv Rev 2022;:114561. [PMID: 36191861 DOI: 10.1016/j.addr.2022.114561] [Reference Citation Analysis]
7 Gu Y, Duan J, Yang N, Yang Y, Zhao X. mRNA vaccines in the prevention and treatment of diseases. MedComm 2022;3. [DOI: 10.1002/mco2.167] [Reference Citation Analysis]
8 Kumar R, Dkhar DS, Kumari R, Divya, Mahapatra S, Dubey VK, Chandra P. Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect. Journal of Drug Delivery Science and Technology 2022;74:103526. [DOI: 10.1016/j.jddst.2022.103526] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Siavashy S, Soltani M, Ahmadi M, Landi B, Mehmanparast H, Ghorbani‐bidkorbeh F. A Comprehensive Review of One Decade of Microfluidic Platforms Applications in Synthesis of Enhanced Carriers Utilized in Controlled Drug Delivery. Adv Materials Technologies. [DOI: 10.1002/admt.202101615] [Reference Citation Analysis]
10 Kesavan A, Chandrasekhar Reddy U, Kurian J, Muraleedharan KM. Cancer cell uptake and distribution of oxanorbornane-based synthetic lipids and their prospects as novel drug delivery systems. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103439] [Reference Citation Analysis]
11 Mukherjee D, Bhatt S. Biocomposite-based nanostructured delivery systems for treatment and control of inflammatory lung diseases. Nanomedicine (Lond) 2022. [PMID: 35477308 DOI: 10.2217/nnm-2021-0425] [Reference Citation Analysis]
12 Crintea A, Dutu AG, Sovrea A, Constantin AM, Samasca G, Masalar AL, Ifju B, Linga E, Neamti L, Tranca RA, Fekete Z, Silaghi CN, Craciun AM. Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. Nanomaterials (Basel) 2022;12:1376. [PMID: 35458084 DOI: 10.3390/nano12081376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sengel-turk CT, Ozkan E, Bakar-ates F. Box-Behnken Design Optimization and In Vitro Cell Based Evaluation of Piroxicam Loaded Core-Shell Type Hybrid Nanocarriers for Prostate Cancer. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.114799] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Scherließ R, Bock S, Bungert N, Neustock A, Valentin L. Particle engineering in dry powders for inhalation. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
15 Robertson I, Wai Hau T, Sami F, Sajid Ali M, Badgujar V, Murtuja S, Saquib Hasnain M, Khan A, Majeed S, Tahir Ansari M. The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ahmad Dar S, Abd Al Galil FM. Biodegradation, Biosynthesis, Isolation, and Applications of Chitin and Chitosan. Handbook of Biodegradable Materials 2022. [DOI: 10.1007/978-3-030-83783-9_72-1] [Reference Citation Analysis]
17 Andrews J, Gkountouna O, Blaisten-barojas E. Forecasting molecular dynamics energetics of polymers in solution from supervised machine learning. Chem Sci 2022;13:7021-33. [DOI: 10.1039/d2sc01216b] [Reference Citation Analysis]
18 Delello Di Filippo L, Hofstätter Azambuja J, Paes Dutra JA, Tavares Luiz M, Lobato Duarte J, Nicoleti LR, Olalla Saad ST, Chorilli M. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. Eur J Pharm Biopharm 2021;168:76-89. [PMID: 34461214 DOI: 10.1016/j.ejpb.2021.08.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
19 Pandey M, Ojha D, Bansal S, Rode AB, Chawla G. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases. Mol Aspects Med 2021;:101003. [PMID: 34332771 DOI: 10.1016/j.mam.2021.101003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]